GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a truly shift in how we handle type 2 diabetes . These injectable therapies work by stimulating the body’s own GLP-1 substance , which promotes https://bookmarksurl.com/story7366756/glp-1-a-significant-advance-in-blood-sugar-care